When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Transtornos de tique

Last reviewed: 13 Jul 2025
Last updated: 17 Nov 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • tiques observados
  • sensação premonitória
  • capacidade de suprimir os tiques
  • os sintomas podem melhorar em caso de distração
  • restante do exame neurológico normal
Full details

Other diagnostic factors

  • os sintomas se agravam com estresse, ansiedade, agitação ou transições
  • intensidade variável ao longo do tempo
  • sintomas de transtorno psiquiátrico comórbido
Full details

Risk factors

  • início com <18 anos de idade
  • sexo masculino
  • história familiar de tiques
  • história familiar de transtorno obsessivo-compulsivo (TOC), TDAH ou depressão
  • tabagismo materno pré-natal
  • história de TOC ou TDAH
  • história de transtorno do espectro autista (TEA)
Full details

Diagnostic investigations

1st investigations to order

  • diagnóstico clínico
Full details

Investigations to consider

  • ressonância nuclear magnética (RNM) cranioencefálica com e sem contraste
  • eletroencefalograma
  • análise do líquido cefalorraquidiano (punção lombar)
Full details

Treatment algorithm

ACUTE

sintomas que não interferem nas atividades da vida diária

sintomas que interferem nas atividades da vida diária: não gestantes

tiques graves refratários a terapias comportamentais e farmacológicas

sintomas que interferem nas atividades da vida diária: gestantes

Contributors

Authors

Tamara Pringsheim, MD, FRCPC

Professor

University of Calgary

Department of Clinical Neurosciences, Psychiatry, Pediatrics, and Community Health Sciences

Calgary

Canada

Disclosures

TP has received research grants for Tourette's syndrome from Alberta Health and the Alberta Children's Hospital Research Institute. TP is an author of several references cited in this topic.

Acknowledgements

Professor Tamara Pringsheim would like to gratefully acknowledge Dr Tanya K. Murphy, Dr Fatima Masumova, Dr Cathy L. Budman, Dr Amber Stocco, Dr Migvis Monduy, and Dr Bobbi Hopkins, previous contributors to this topic.

Disclosures

FM, AS, MM, and BH declare that they have no competing interests. TKM has received research grants from Auspex Pharmaceuticals, the National Institute of Mental Health, Shire Pharmaceuticals, Pfizer Inc., F. Hoffman-La Roche Ltd., AstraZeneca Pharmaceuticals, Centers for Disease Control and Prevention, Massachusetts General Hospital, Sunovion Pharmaceuticals, Neurocrine Bioscience, Psyadon Pharmaceuticals, and PANDAS Network; she is on the advisory board for the International Obsessive Compulsive Foundation; she is also an author of several references cited in this topic. CLB has received research funding from Otsuka, Psyadon, Auspex, Teva, Neurocrine, and Synchroneuron Pharmaceuticals; she is a consultant for Bracket and a paid speaker for the Centers for Disease Control and Prevention (CDC) - National Tourette Syndrome Association Partnership; she is an author of several references cited in this topic.

Peer reviewers

Francis Filloux, MD

Chief

Division of Pediatric Neurology

University of Utah School of Medicine

Salt Lake City

UT

Disclosures

FF declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Murphy TK, Lewin AB, Storch EA, et al. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1341-59.Full text  Abstract

Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):896-906.Full text  Abstract

Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):907-15.Full text  Abstract

Kuo SH, Jimenez-Shahed J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol. 2010 Jan-Feb;33(1):32-4. Abstract

Bloch MH, Panza KE, Landeros-Weisenberger A, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-93.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Comportamentos funcionais semelhantes a tiques
    • Transtorno obsessivo-compulsivo (TOC)
    • Estereotipias
    More Differentials
  • Guidelines

    • Diagnosing tic disorders
    • Treatment of tics in people with Tourette syndrome and chronic tic disorders
    More Guidelines
  • Patient information

    Transtorno obsessivo-compulsivo

    TDAH: o que é?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer